Inc. has announced a definitive merger agreement under which BMS will acquire all of the outstanding shares of 2seventy bio.
7h
Zacks Investment Research on MSNBiotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & MoreMergers and acquisitions grabbed the spotlight in the biotech sector once again this week after Bristol Myers Squibb BMY ...
Philadelphia-based Endo sold its international pharma unit to Knight Therapeutics this week for up to $99 million, while Ireland-headquartered Mallinckrodt sold Therakos, a specialist in ...
Morgan Stanley analyst Ravi Shanker maintained a Hold rating on JetBlue Airways (JBLU – Research Report) today and set a price target of $8.00.
Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B. Check out the portfolio's top holdings and notable stake ...
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results